Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Sector performance is calculated based on the previous closing price of all sector constituents
Industries in This Sector
Select an Industry for a Visual Breakdown
| Industry | Market Weight | Day Return | YTD Return |
|---|---|---|---|
| All Industries | 100% | 0.01% | 4.43% |
| Drug Manufacturers - General | 33.99% | -0.06% | 9.92% |
| Healthcare Plans | 13.69% | 0.07% | -0.36% |
| Medical Devices | 12.79% | -0.61% | 5.11% |
| Biotechnology | 11.51% | 0.85% | -2.01% |
| Diagnostics & Research | 11.03% | -0.52% | 0.77% |
| Medical Instruments & Supplies | 6.69% | -0.01% | 5.57% |
| Drug Manufacturers - Specialty & Generic | 2.94% | 0.91% | 2.55% |
| Medical Care Facilities | 2.75% | 0.33% | 6.09% |
| Medical Distribution | 2.29% | 0.79% | 6.82% |
| Health Information Services | 2.02% | 0.45% | 4.05% |
| Pharmaceutical Retailers | 0.29% | -1.57% | -14.91% |
All Industries
-
Note: Percentage % data on heatmap indicates Day Return
Largest Companies in This Sector
Name | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
|---|---|---|---|---|---|---|---|
| 740.16 | 730.41 | 10.70% | Buy | ||||
| 518.22 | 599.98 | 7.33% | Buy | ||||
| 156.76 | 175.05 | 5.75% | Buy | ||||
| 125.45 | 133.18 | 4.89% | Buy | ||||
| 174.08 | 176.50 | 4.70% | Buy | ||||
| 550.75 | 593.24 | 3.24% | Buy | ||||
| 111.81 | 125.37 | 2.97% | Buy | ||||
| 242.95 | 260.20 | 2.77% | Buy | ||||
| 291.12 | 305.41 | 2.37% | Buy | ||||
| 27.56 | 32.14 | 2.37% | Buy |
Investing in the Healthcare Sector
Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds
ETF Opportunities
Name | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 144.01 | 39.294B | 0.09% | ||
| 263.45 | 19.913B | 0.10% | ||
| 134.59 | 7.338B | 0.45% | ||
| 91.04 | 6.624B | 0.35% | ||
| 56.72 | 5.449B | 0.40% |
Mutual Fund Opportunities
Name | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 215.22 | 46.292B | 0.34% | ||
| 90.75 | 46.292B | 0.34% | ||
| 131.85 | 19.913B | 0.10% | ||
| 93.10 | 14.847B | 0.80% | ||
| 93.34 | 14.712B | 0.80% |
Healthcare Research
Discover the Latest Analyst and Technical Research for This Sector
Analyst Report: ICON Public Limited Company
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
RatingBearishPrice TargetMorningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover
In this edition, we say viva Veeva; the China housing market is building up to something positive; computer software has a great future; and Sensata, Sunny Optical, and Onsemi.
Analyst Report: AptarGroup, Inc.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (50% of sales) and the United States (33%), Aptar aims to increase its presence in Asia (10%) and Latin America (7%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
RatingNeutralPrice TargetAnalyst Report: IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
RatingBearishPrice Target

